Advertisement

Psychiatric Emergencies in Older Adults

  • Timothy E. Lau
  • Sarah Russell
  • Elizabeth Kozyra
  • Sophiya Benjamin
Chapter

Abstract

Over the last few decades, in keeping with the demographic shift associated with an aging population, there has been a consistent increase in the number of geriatric patients visiting emergency departments across North America. The assessment of older adults for psychiatric emergencies is complicated by increased systemic medical and cognitive comorbidities, higher rates of polypharmacy, and a greater sensitivity to medications. Adding further complications to the care of older adults is a psychosocial issue associated with a fixed/limited income, the potential for elder abuse, and questions of level of decisional capacity. This chapter reviews the assessment, diagnosis, and management of the common psychiatric emergencies among the geriatric population, including delirium, major depressive disorder with suicidality, major neurocognitive disorder (dementia) accompanied by neuropsychiatric symptoms, elder abuse, and emergencies associated with psychotropic medications.

Keywords

Geriatric psychiatric emergencies Delirium Suicide Substance abuse Elder abuse Dementia Major neurocognitive disorder Aged Geriatric 

References

  1. 1.
    Sikka V, Kalra S, Galwankar S. Psychiatric emergencies in the elderly. Emerg Med Clin North Am. 2015;33:825–39.CrossRefPubMedGoogle Scholar
  2. 2.
    Canadian Centre for Health Information. Health Care in Canada 2011. Focus on Seniors and Aging. https://secure.cihi.ca/free_products/HCIC_2011_seniors_report_en.pdf. Accessed 12 May 2017.
  3. 3.
    Tueth MJ, Zuberi P. Life-threatening psychiatric emergencies in the elderly: overview. J Geriatr Psychiatry Neurol. 1999;12:60–6.CrossRefPubMedGoogle Scholar
  4. 4.
    Inouye SK. Delirium in older persons. N Engl J Med. 2006;354(11):1157–65.CrossRefPubMedGoogle Scholar
  5. 5.
    American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th edition (DSM-5). 5th ed. Washington, DC: American Psychiatric Publishing; 2013.CrossRefGoogle Scholar
  6. 6.
    Lau T. Dementia: diagnosis and screening tools. Can J Diagn. 2009;26(11):119–22.Google Scholar
  7. 7.
    Galvin JE, Roe CM, Powlishta KK, et al. The AD8: a brief informant interview to detect dementia. Neurology. 2005;65(4):559–64.CrossRefPubMedGoogle Scholar
  8. 8.
    McKeith I. Dementia with Lewy bodies. Dialogues Clin Neurosci. 2004;6(3):333–41.PubMedPubMedCentralGoogle Scholar
  9. 9.
    McCusker J, Cole M, Dendukuri N, et al. The course of delirium in older medical inpatients: a prospective study. J Gen Intern Med. 2003;18:696–704.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Saxena S, Lawley D. Delirium in the elderly: a clinical review. Postgrad Med J. 2009;85:405–13.CrossRefPubMedGoogle Scholar
  11. 11.
    Elie M, Rousseau F, Cole M, et al. Prevalence and detection of delirium in elderly emergency department patients. CMAJ. 2000;163(8):977–81.PubMedPubMedCentralGoogle Scholar
  12. 12.
    Tabet N, Howard R. Non-pharmacological interventions in the prevention of delirium. Age Ageing. 2009;38:374–9.CrossRefPubMedGoogle Scholar
  13. 13.
    Inouye SK, Bogardus ST Jr, Charpentier PA, et al. A multicomponent intervention to prevent delirium in hospitalized older adults. N Engl J Med. 1999;340:669–76.CrossRefPubMedGoogle Scholar
  14. 14.
    Inouye SK, Bogardus ST Jr, Baker DI, Leo-Summers L, Cooney LM Jr. The Hospital Elder Life Program: a model of care to prevent delirium and functional decline in hospitalized older patients. J Am Geriatr Soc. 2000;48:1697–706.CrossRefPubMedGoogle Scholar
  15. 15.
    Caplan GA, Harper EL. Recruitment of volunteers to improve vitality in the elderly: the REVIVE study. Intern Med J. 2007;37:95–100.CrossRefPubMedGoogle Scholar
  16. 16.
    Strijbos MJ, Steunenberg B, van der Mast RC, Inouye SK, Schuurmans MJ. Design and methods of the Hospital Elder Life Program (HELP), a multicomponent targeted intervention to prevent delirium in hospitalized older patients: efficacy and cost-effectiveness in Dutch health care. BMC Geriatr. 2013;13:78.  https://doi.org/10.1186/1471–2318–13–78.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Alagiakrishnan K, Wiens CA. An approach to drug induced delirium in the elderly. Postgrad Med J. 2004;80(945):388–93.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Flacker JM, Cummings V, Mach JR, et al. An association between serum anticholinergic activity and delirium in elderly medical patients has been documented. Am J Geriatr Psychiatry. 1998;6:31–41.CrossRefPubMedGoogle Scholar
  19. 19.
    Han L, McCusker J, Cole M, et al. Use of medications with anticholinergic effect predicts clinical severity of delirium symptoms in older medical inpatients. Arch Intern Med. 2001;161:1099–105.CrossRefPubMedGoogle Scholar
  20. 20.
    Siddiqi N, Harrison JK, Clegg A, et al. Interventions for preventing delirium in hospitalized non-ICU patients. Cochrane Database Syst Rev. 2016;3:CD005563.PubMedGoogle Scholar
  21. 21.
    Popeo DM. Delirium in older adults. Mt Sinai J Med. 2011;78(4):571–82.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Krug EG, Dahlberg LL, Mercy JA, et al., editors. World report on violence and health. Geneva: World Health Organization; 2002.Google Scholar
  23. 23.
    McIntosh JL, Santos JF, Hubbard RW, et al. Elderly suicide: research, theory, and treatment. Washington (DC): American Psychological Association; 1994.CrossRefGoogle Scholar
  24. 24.
    Conwell Y, Duberstein PR, Cox C, et al. Age differences in behaviors leading to completed suicide. Am J Geriatr Psychiatry. 1998;6(2):122–6.CrossRefPubMedGoogle Scholar
  25. 25.
    Heisel MJ, Grek A, Moore SL. National guidelines for seniors’ mental health: the assessment of suicide risk and prevention of suicide. Can J Geriatr. 2006;9(Suppl 2):S65–70.Google Scholar
  26. 26.
    Ohberg A, Lonnqvist J. Suicides hidden among undetermined deaths. Acta Psychiatr Scand. 1998;98:214–8.CrossRefPubMedGoogle Scholar
  27. 27.
    Conwell Y, Van Orden K, Caine E. Suicide in older adults. Psychiatr Clin North Am. 2011;34(2):451–68.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Turvey CL. Risk factors for late-life suicide: a prospective, community-based study. Am J Geriatr Psychiatry. 2002;10(4):398–406.CrossRefPubMedGoogle Scholar
  29. 29.
    Pearson JL, Brown GK. Suicide prevention in late life: direction for science and practice. Clin Psychol Rev. 2000;20:685–705.CrossRefPubMedGoogle Scholar
  30. 30.
    Waern M, Beskow J, Runeson B, Skoog I. Suicidal feelings in the last year of life in elderly people who commit suicide. Lancet. 1999;354:917–8.CrossRefPubMedGoogle Scholar
  31. 31.
    Batterham PJ. A systematic review and evaluation of measures for suicidal ideation and behaviors in population-based research. Psychol Assess. 2015;27(2):501–12.CrossRefPubMedGoogle Scholar
  32. 32.
    Warden S, Spiwak R, Sareen J, Bolton JM. The SAD PERSONS scale for suicide risk assessment: a systematic review. Arch Suicide Res. 2014;18(4):313–26.CrossRefPubMedGoogle Scholar
  33. 33.
    Heisel MJ. Screening for suicide ideation among older primary care patients. J Am Board Fam Med. 2010;23(2):260–9.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Fischer LR, Wei F, Solberg LI, et al. Treatment of elderly and other adult patients for depression in primary care. J Am Geriatr Soc. 2003;51:1554–62.CrossRefPubMedGoogle Scholar
  35. 35.
    Duberstein PR, Conwell Y, Seidlitz L, et al. Age and suicidal ideation in older depressed inpatients. Am J Psychiatry. 1999;7(4):289–96.Google Scholar
  36. 36.
    Gallo JJ, Rabins PV, Anthony JC. Sadness in older persons: a 13- year follow-up of a community sample in Baltimore, Maryland. Psychol Med. 1999;29:341–50.CrossRefPubMedGoogle Scholar
  37. 37.
    Griffiths JJ, Zarate CA Jr, Rasimas JJ. Existing and novel biological therapeutics in suicide prevention. Am J Prev Med. 2014;47(3 Suppl 2):S195–203.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Al Jurdi RK, Swann A, Mathew SJ. Psychopharmacological agents and suicide risk reduction: ketamine and other approaches. Curr Psychiatry Rep. 2015;17(10):81.CrossRefPubMedGoogle Scholar
  39. 39.
    Bruce ML, Ten Have TR, Reynolds CF III, et al. Reducing suicidal ideation and depressive symptoms in depressed older primary care patients. A randomized controlled trial. JAMA. 2004;291(9):1081–91.CrossRefPubMedGoogle Scholar
  40. 40.
    Lebowitz BD, Pearson JL, Schneider LS, et al. Diagnosis and treatment of depression in late life. Consensus statement update. JAMA. 1997;278(14):1186–90.CrossRefPubMedGoogle Scholar
  41. 41.
    Schwenk TL. Diagnosis of late life depression: the view from primary care. Biol Psychiatry. 2002;52:157–63.CrossRefPubMedGoogle Scholar
  42. 42.
    Butters MA, Whyte EM, Nebes RD, et al. The nature and determinants of neuropsychological functioning in late-life depression. Arch Gen Psychiatry. 2004;61:587–95.CrossRefPubMedGoogle Scholar
  43. 43.
    Conwell Y. Suicide and suicide prevention in late life. Focus. 2013;11:39–47.CrossRefGoogle Scholar
  44. 44.
    Byers AL, Arean PA, Yaffe K. Low use of mental health services among older Americans with mood and anxiety disorders. Psychiatr Serv. 2012;63(1):66–72.CrossRefPubMedPubMedCentralGoogle Scholar
  45. 45.
    Unützer J, Tang L, Oishi S, et al. Reducing suicidal ideation in depressed older primary care patients. J Am Geriatr Soc. 2006;54:1550–6.CrossRefPubMedGoogle Scholar
  46. 46.
    Lachs MS, Pillemer KA. Elder abuse. N Engl J Med. 2015;373(20):1947–56.CrossRefPubMedGoogle Scholar
  47. 47.
    Kales HC. State of the art review: assessment and management of behavioral and psychological symptoms of dementia. BMJ. 2015;350:h369.CrossRefPubMedPubMedCentralGoogle Scholar
  48. 48.
    Katz I, de Deyn PP, Mintzer J, et al. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer’s disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials. Int J Geriatr Psychiatry. 2007;22(5):475–84.CrossRefPubMedGoogle Scholar
  49. 49.
    Porsteinsson AP, Drye LT, Pollock BG. Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial. JAMA. 2014;311(7):682–91.CrossRefPubMedPubMedCentralGoogle Scholar
  50. 50.
    Friedman LS, Avila S, Tanouye K, et al. A case-control study of severe physical abuse of older adults. J Am Geriatr Soc. 2011;59(3):417–22.CrossRefPubMedGoogle Scholar
  51. 51.
    Lachs MS, Williams CS, O’Brien S, et al. ED use by older victims of family violence. Ann Emerg Med. 1997;30:448–54.CrossRefPubMedGoogle Scholar
  52. 52.
    Tisdale JE. Drug-induced QT interval prolongation and torsades de pointes. Role of the pharmacist in risk assessment, prevention and management. Can Pharm J (Ott). 2016;149(3):139–52.CrossRefGoogle Scholar
  53. 53.
    G L, Milionis H, Elisaf M. A review of drug-induced hyponatremia. Am J Kidney Dis. 2008;52(1):144–53.CrossRefGoogle Scholar
  54. 54.
    Zalewska-Janowska A, Spiewak R, Kowalski ML. Cutaneous manifestation of drug allergy and hypersensitivity. Immunol Allergy Clin N Am. 2017;37(1):165–81.CrossRefGoogle Scholar
  55. 55.
    EW B, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352:1112–20.CrossRefGoogle Scholar
  56. 56.
    Barry AR, Windram JD, Graham MM. Clozapine-associated myocarditis: case report and literature review. Can J Hosp Pharm. 2015;68(5):427–9.PubMedPubMedCentralGoogle Scholar
  57. 57.
    La Grenade L, Graham D, Trontell A. Myocarditis and cardiomyopathy associated with clozapine use in the United States. N Engl J Med. 2001;345(3):224–5.CrossRefPubMedGoogle Scholar
  58. 58.
    Mackin P. Cardiac side effects of psychiatric drugs. Hum Psychopharmacol Clin Exp. 2008;23:3–14.CrossRefGoogle Scholar
  59. 59.
    Washington NB, Brahm NC, Kissack J. Which psychotropics carry the greatest risk of QTc prolongation? Curr Psychiatr Ther. 2012;11(10):36–9.Google Scholar
  60. 60.
    Woosley RL, Romero KA. www.Crediblemeds.org, QTdrugs List, Accession Date, AZCERT, Inc. 1822 Innovation Park Dr., Oro Valley, AZ 85755.
  61. 61.
    Haddad PM, Dursun SM. Neurological complications of psychiatric drugs: clinical features and management. Hum Psychopharmacol Clin Exp. 2008;23:15–26.CrossRefGoogle Scholar
  62. 62.
    Anglin R, Yuan Y, Moayyedi P, et al. Risk of upper gastrointestinal bleeding with selective serotonin reuptake inhibitors with or without concurrent nonsteroidal anti-inflammatory use: a systematic review and meta-analysis. Am J Gastroenterol. 2014;109(6):811–9.CrossRefPubMedGoogle Scholar
  63. 63.
    Gandhi S, Shariff SZ, Al-Jaishi A. Second-generation antidepressants and hyponatremia risk: a population-based cohort study of older adults. Am J Kidney Dis. 2017;69(1):87–96.CrossRefPubMedGoogle Scholar
  64. 64.
    Hohl CM, Dankoff J, Colacone A, et al. Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department. Ann Emerg Med. 2001;38:666–71.CrossRefPubMedGoogle Scholar
  65. 65.
    Kalisvaart KJ, de Jonghe JF, Bogaards MJ, et al. Haloperidol prophylaxis for elderly hip-surgery patients at risk for delirium: a randomized placebo-controlled study. J Am Geriatr Soc. 2005;53(10):1658–66.CrossRefPubMedGoogle Scholar
  66. 66.
    Sddiqi N, Harrison JK, Clegg A, Teale EA, Young J, Taylor J, Simpkins SA. Interventions for preventing delirium in hospitalised non-ICU patients. Cochrane Database Syst Rev. 2016;(3):CD005563.Google Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Timothy E. Lau
    • 1
  • Sarah Russell
    • 2
  • Elizabeth Kozyra
    • 1
  • Sophiya Benjamin
    • 3
  1. 1.Royal Ottawa Mental Health CentreOttawaCanada
  2. 2.The Ottawa HospitalOttawaCanada
  3. 3.McMaster UniversityKitchenerCanada

Personalised recommendations